The heat shock transcription factor HSF-1 activates transcription of target genes that promote protein homeostasis, implying important roles for HSF-1 in stress tolerance, aging, innate immunity, cancer, and protein diseases. Because active HSF-1 mediates resistance to a wide variety of proteotoxic stressors, drugs that upregulate HSF-1 may be therapeutic for a variety of protein misfolding diseases, such as Huntington's disease. Recent studies suggest, however, that HSF-1 activity may also be involved in undesirable phenotypes, including cellular transformation to a cancerous state. While global regulation of HSF-1 might be undesirable, identification of regulators of HSF-1 may allow us to find more nuanced ways to control its activity. Additionally, while many HSF-1-dependent processes have been extensively studied in the model organism Caenorhabditis elegans, the molecular behavior of HSF-1 has not yet been characterized in this system. We have begun to examine molecular characteristics of HSF-1 in C. elegans using a fluorescently tagged HSF-1. Tagged HSF-1 appears to localize to the nucleus under basal conditions and to condense into nuclear granules upon heat shock. To identify HSF-1 regulators, we conducted a high-throughput RNAi screen on an HSF-1-dependent reporter strain of C. elegans. Our screen covered 17,540 genes and identified 44 regulators of the HSF-1-dependent reporter. RNAi inhibition of these genes did not similarly affect an HSF-1-independent reporter, suggesting that they specifically regulate HSF-1-dependent phenotypes. One gene identified by our screen was
smo-1, which encodes the sole C. elegans SUMO homolog. SUMO is a small ubiquitin-like molecule used to post-translationally modify proteins. Repression of
smo-1 led to hyper-activation of the HSF1-dependent reporter, but only following activation of the reporter by heat shock. Consistent with this phenotype,
smo-1(RNAi) also improved whole-animal thermotolerance. Sequence analysis of HSF-1 revealed a consensus site for sumoylation at the N-terminus, and recent studies from other labs confirm that HSF1 is post-translationally sumoylated. These results suggest that SUMO may directly modify HSF-1 in C. elegans in response to specific activating conditions and that such modifications inhibit HSF-1-regulated gene expression and stress resistance in vivo. Our findings have implications for sumoylation as a future target for therapies intended to regulate HSF-1.